220
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor—the importance of gastrointestinal pH and solubility for the in vivo exposure

, &
Pages 1036-1042 | Received 05 Jul 2010, Accepted 25 Jan 2011, Published online: 21 Mar 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Kalle Sigfridsson, Anders Lundqvist & Marie Strimfors. (2014) Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats. Drug Development and Industrial Pharmacy 40:4, pages 511-518.
Read now
Kalle Sigfridsson, Anders Lundqvist & Marie Strimfors. (2013) Evaluation of exposure properties after injection of nanosuspensions and microsuspenions into the intraperitoneal space in rats. Drug Development and Industrial Pharmacy 39:11, pages 1832-1839.
Read now
Ajazuddin, Amit Alexander, Basant Amarji & Parijat Kanaujia. (2013) Synthesis, characterization and in vitro studies of pegylated melphalan conjugates. Drug Development and Industrial Pharmacy 39:7, pages 1053-1062.
Read now
Kwan Hyung Cho & Han-Gon Choi. (2013) Development of novel bepotastine salicylate salt bioequivalent to the commercial bepotastine besilate in beagle dogs. Drug Development and Industrial Pharmacy 39:6, pages 901-908.
Read now
Lan Wang, Yanli Hao, Nan Liu, Mingshu Ma, Zhe Yin & Xiaoning Zhang. (2012) Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method. Drug Development and Industrial Pharmacy 38:11, pages 1381-1389.
Read now

Articles from other publishers (2)

Jaydeep Patel, Anjali Dhingani, Kevin Garala, Mihir Raval & Navin Sheth. (2014) Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis. Powder Technology 258, pages 331-343.
Crossref
Jan P. Möschwitzer. (2013) Drug nanocrystals in the commercial pharmaceutical development process. International Journal of Pharmaceutics 453:1, pages 142-156.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.